Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Dialysis | 12 | 2023 | 1789 | 1.220 |
Why?
|
Pruritus | 2 | 2023 | 379 | 1.220 |
Why?
|
Urologic Diseases | 1 | 2020 | 247 | 0.560 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2022 | 2297 | 0.550 |
Why?
|
Education, Medical, Undergraduate | 10 | 2007 | 1085 | 0.530 |
Why?
|
Peritonitis, Tuberculous | 1 | 2013 | 6 | 0.430 |
Why?
|
Family Practice | 6 | 2011 | 509 | 0.400 |
Why?
|
Kidney Failure, Chronic | 11 | 2020 | 2493 | 0.390 |
Why?
|
Sternum | 1 | 2013 | 177 | 0.390 |
Why?
|
Peritoneum | 1 | 2013 | 231 | 0.380 |
Why?
|
Curriculum | 9 | 2011 | 3782 | 0.380 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2022 | 291 | 0.340 |
Why?
|
Osteomyelitis | 1 | 2013 | 408 | 0.310 |
Why?
|
Schools, Medical | 5 | 2010 | 883 | 0.270 |
Why?
|
Education, Medical | 2 | 2010 | 1742 | 0.270 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2013 | 843 | 0.260 |
Why?
|
Clinical Clerkship | 4 | 2011 | 569 | 0.260 |
Why?
|
Patient Simulation | 1 | 2008 | 297 | 0.250 |
Why?
|
Kidney Function Tests | 3 | 2019 | 684 | 0.250 |
Why?
|
Case Management | 1 | 2007 | 277 | 0.240 |
Why?
|
Nephritis, Hereditary | 1 | 2004 | 78 | 0.240 |
Why?
|
Preceptorship | 3 | 2001 | 57 | 0.230 |
Why?
|
Attitude to Computers | 2 | 2002 | 196 | 0.230 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2023 | 17 | 0.220 |
Why?
|
Hematuria | 1 | 2004 | 233 | 0.220 |
Why?
|
Empathy | 1 | 2008 | 476 | 0.220 |
Why?
|
Outpatients | 2 | 2012 | 1603 | 0.220 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2339 | 0.210 |
Why?
|
Uremia | 3 | 2015 | 202 | 0.200 |
Why?
|
Calciphylaxis | 2 | 2015 | 129 | 0.200 |
Why?
|
Faculty, Medical | 4 | 2007 | 1226 | 0.190 |
Why?
|
Computer-Assisted Instruction | 2 | 2002 | 366 | 0.190 |
Why?
|
Models, Educational | 2 | 2001 | 375 | 0.190 |
Why?
|
Problem-Based Learning | 3 | 2007 | 360 | 0.190 |
Why?
|
Educational Measurement | 2 | 2008 | 1260 | 0.190 |
Why?
|
Editorial Policies | 1 | 2006 | 460 | 0.180 |
Why?
|
Micropore Filters | 1 | 2020 | 22 | 0.180 |
Why?
|
Hyponatremia | 1 | 2023 | 279 | 0.180 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2004 | 391 | 0.180 |
Why?
|
Patient Care Management | 2 | 2019 | 304 | 0.170 |
Why?
|
Acidosis | 1 | 2022 | 271 | 0.170 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.170 |
Why?
|
Nebraska | 5 | 2004 | 33 | 0.160 |
Why?
|
Communication | 4 | 2008 | 3908 | 0.150 |
Why?
|
Thiosulfates | 2 | 2015 | 52 | 0.140 |
Why?
|
Patients | 1 | 2023 | 908 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 317 | 0.140 |
Why?
|
Lymphocyte Cooperation | 1 | 1996 | 112 | 0.130 |
Why?
|
Kidney | 2 | 2016 | 7058 | 0.130 |
Why?
|
Students, Medical | 4 | 2002 | 1964 | 0.120 |
Why?
|
Cryoglobulinemia | 1 | 2015 | 84 | 0.120 |
Why?
|
Video Recording | 1 | 2020 | 976 | 0.120 |
Why?
|
Periodicals as Topic | 1 | 2006 | 1470 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2020 | 965 | 0.120 |
Why?
|
Graft Occlusion, Vascular | 2 | 2022 | 538 | 0.110 |
Why?
|
Lung | 1 | 2013 | 10099 | 0.110 |
Why?
|
Ribavirin | 1 | 2015 | 395 | 0.110 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2016 | 1459 | 0.110 |
Why?
|
Heparin | 1 | 2020 | 1636 | 0.110 |
Why?
|
Clinical Competence | 2 | 2008 | 4860 | 0.100 |
Why?
|
Humans | 56 | 2023 | 768970 | 0.100 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 41 | 0.100 |
Why?
|
BK Virus | 1 | 2013 | 120 | 0.100 |
Why?
|
Cefazolin | 1 | 2012 | 95 | 0.100 |
Why?
|
Isoantibodies | 1 | 1996 | 681 | 0.100 |
Why?
|
Electronic Health Records | 2 | 2020 | 4879 | 0.100 |
Why?
|
Chelating Agents | 1 | 2013 | 385 | 0.100 |
Why?
|
Peritoneal Dialysis | 1 | 2013 | 160 | 0.100 |
Why?
|
Interferon-alpha | 1 | 2015 | 910 | 0.090 |
Why?
|
Dilatation, Pathologic | 1 | 2013 | 527 | 0.090 |
Why?
|
Renal Replacement Therapy | 1 | 2013 | 282 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2008 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1493 | 0.090 |
Why?
|
Vascular Patency | 3 | 2022 | 917 | 0.080 |
Why?
|
Islets of Langerhans Transplantation | 1 | 1994 | 748 | 0.080 |
Why?
|
Transplantation, Heterologous | 2 | 1995 | 2395 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 1992 | 692 | 0.080 |
Why?
|
Texas | 1 | 2010 | 410 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2015 | 790 | 0.080 |
Why?
|
Vancomycin | 1 | 2012 | 506 | 0.080 |
Why?
|
Extravascular Lung Water | 1 | 2009 | 21 | 0.080 |
Why?
|
Diabetic Nephropathies | 2 | 2015 | 973 | 0.080 |
Why?
|
Disease Management | 2 | 2016 | 2537 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2000 | 3928 | 0.080 |
Why?
|
Role Playing | 1 | 2008 | 21 | 0.080 |
Why?
|
Collagen | 2 | 1996 | 2646 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1994 | 1124 | 0.080 |
Why?
|
Albuminuria | 1 | 1992 | 658 | 0.080 |
Why?
|
Urinary Incontinence | 1 | 1992 | 496 | 0.080 |
Why?
|
Electrolytes | 2 | 2022 | 279 | 0.070 |
Why?
|
Philosophy, Medical | 1 | 2008 | 78 | 0.070 |
Why?
|
Neoplasms | 1 | 2017 | 22389 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 2011 | 592 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2754 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 1033 | 0.070 |
Why?
|
Sociology, Medical | 1 | 1987 | 62 | 0.070 |
Why?
|
Humanism | 1 | 2008 | 85 | 0.070 |
Why?
|
Sodium | 2 | 2023 | 1597 | 0.070 |
Why?
|
Physician-Patient Relations | 4 | 2008 | 3269 | 0.070 |
Why?
|
Radiography | 3 | 2013 | 6991 | 0.070 |
Why?
|
Nurse Administrators | 1 | 2007 | 45 | 0.070 |
Why?
|
Anticoagulants | 2 | 2020 | 4850 | 0.070 |
Why?
|
Registries | 2 | 2022 | 8384 | 0.070 |
Why?
|
Abdominal Pain | 1 | 2013 | 1070 | 0.070 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2013 | 799 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2009 | 409 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 13021 | 0.060 |
Why?
|
Narration | 1 | 2008 | 223 | 0.060 |
Why?
|
Aged | 18 | 2020 | 171786 | 0.060 |
Why?
|
Female | 29 | 2022 | 397515 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4056 | 0.060 |
Why?
|
Bone Marrow Neoplasms | 1 | 2006 | 101 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3904 | 0.060 |
Why?
|
Bacteremia | 1 | 2012 | 985 | 0.060 |
Why?
|
Systems Theory | 1 | 2005 | 57 | 0.060 |
Why?
|
Angiomyolipoma | 1 | 2006 | 189 | 0.060 |
Why?
|
Tissue Donors | 1 | 1995 | 2382 | 0.060 |
Why?
|
Organ Transplantation | 1 | 1995 | 1178 | 0.060 |
Why?
|
Glomerulonephritis, IGA | 1 | 2004 | 61 | 0.060 |
Why?
|
Cystitis | 1 | 2004 | 96 | 0.060 |
Why?
|
Collagen Type IV | 1 | 2004 | 125 | 0.060 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2006 | 207 | 0.060 |
Why?
|
Staphylococcus aureus | 1 | 2012 | 1430 | 0.060 |
Why?
|
Organizational Case Studies | 1 | 2005 | 301 | 0.060 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1104 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2019 | 954 | 0.060 |
Why?
|
Libraries, Medical | 1 | 2004 | 12 | 0.060 |
Why?
|
Treatment Outcome | 11 | 2022 | 65480 | 0.060 |
Why?
|
Basement Membrane | 1 | 2004 | 348 | 0.060 |
Why?
|
Amyloidosis | 1 | 2011 | 879 | 0.060 |
Why?
|
Acute Kidney Injury | 2 | 2013 | 1936 | 0.060 |
Why?
|
Medical History Taking | 1 | 2007 | 779 | 0.060 |
Why?
|
Contrast Media | 1 | 2017 | 5334 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3683 | 0.050 |
Why?
|
Kidney Neoplasms | 2 | 2013 | 4300 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3421 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2015 | 3070 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1996 | 4413 | 0.050 |
Why?
|
Male | 24 | 2022 | 365203 | 0.050 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1388 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 1996 | 4794 | 0.050 |
Why?
|
Teaching | 2 | 2007 | 1171 | 0.050 |
Why?
|
Biopsy | 3 | 2015 | 6805 | 0.050 |
Why?
|
Program Evaluation | 4 | 2007 | 2508 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2007 | 829 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.050 |
Why?
|
Proteinuria | 1 | 2004 | 610 | 0.050 |
Why?
|
Catheterization | 1 | 2007 | 1431 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2022 | 81903 | 0.050 |
Why?
|
Acid-Base Equilibrium | 1 | 2022 | 180 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2936 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5522 | 0.050 |
Why?
|
Middle Aged | 19 | 2020 | 223737 | 0.050 |
Why?
|
Staff Development | 1 | 2003 | 230 | 0.050 |
Why?
|
Learning | 2 | 2001 | 1760 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5176 | 0.040 |
Why?
|
General Surgery | 2 | 2002 | 1722 | 0.040 |
Why?
|
Factor Xa | 1 | 2020 | 166 | 0.040 |
Why?
|
Remission Induction | 3 | 2013 | 2408 | 0.040 |
Why?
|
Program Development | 4 | 2007 | 1300 | 0.040 |
Why?
|
Tuberous Sclerosis | 1 | 2006 | 1042 | 0.040 |
Why?
|
Patient Participation | 1 | 1987 | 1448 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2006 | 2709 | 0.040 |
Why?
|
Behavioral Sciences | 1 | 1998 | 29 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3253 | 0.040 |
Why?
|
Equipment Failure Analysis | 1 | 2020 | 848 | 0.040 |
Why?
|
Heterozygote | 1 | 2004 | 2798 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4265 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12253 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3438 | 0.040 |
Why?
|
Health Services Research | 1 | 2005 | 1818 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1560 | 0.030 |
Why?
|
Case-Control Studies | 5 | 2015 | 22296 | 0.030 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2016 | 36 | 0.030 |
Why?
|
Attitude | 1 | 2001 | 772 | 0.030 |
Why?
|
Comorbidity | 3 | 2016 | 10592 | 0.030 |
Why?
|
Tissue Survival | 1 | 1995 | 120 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1445 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1996 | 306 | 0.030 |
Why?
|
Urinary Incontinence, Stress | 1 | 1996 | 183 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2020 | 1161 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2007 | 2422 | 0.030 |
Why?
|
Arterioles | 1 | 2015 | 252 | 0.030 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2015 | 124 | 0.030 |
Why?
|
Primary Health Care | 2 | 2001 | 4748 | 0.030 |
Why?
|
Quality Improvement | 2 | 2020 | 3860 | 0.030 |
Why?
|
Patient Selection | 2 | 2016 | 4265 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 1996 | 605 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2004 | 2100 | 0.030 |
Why?
|
Zoonoses | 1 | 1995 | 180 | 0.030 |
Why?
|
Vitamin D | 1 | 2007 | 3311 | 0.030 |
Why?
|
Models, Immunological | 1 | 1996 | 518 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5196 | 0.030 |
Why?
|
Splenectomy | 1 | 1994 | 392 | 0.030 |
Why?
|
Survival Rate | 1 | 2007 | 12873 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59739 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 1996 | 1755 | 0.030 |
Why?
|
Adult | 10 | 2022 | 223851 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 1995 | 537 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1076 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2013 | 280 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 1994 | 913 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2003 | 2784 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2006 | 4835 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2019 | 5369 | 0.020 |
Why?
|
Child, Preschool | 5 | 2019 | 42683 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2013 | 39394 | 0.020 |
Why?
|
Risk Factors | 6 | 2016 | 74976 | 0.020 |
Why?
|
United States | 7 | 2016 | 73186 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1996 | 1439 | 0.020 |
Why?
|
Massachusetts | 2 | 2019 | 8894 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2006 | 3200 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1407 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4040 | 0.020 |
Why?
|
Urethra | 1 | 1992 | 407 | 0.020 |
Why?
|
Patient Discharge | 1 | 2004 | 3491 | 0.020 |
Why?
|
Time Factors | 4 | 2016 | 40261 | 0.020 |
Why?
|
Immunoglobulin Light Chains | 1 | 2011 | 289 | 0.020 |
Why?
|
Biogenic Amines | 1 | 2010 | 53 | 0.020 |
Why?
|
Skin Transplantation | 1 | 1996 | 1097 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1836 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3200 | 0.020 |
Why?
|
Pancreatectomy | 1 | 1994 | 825 | 0.020 |
Why?
|
Age Factors | 3 | 2016 | 18435 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4352 | 0.020 |
Why?
|
Dicarboxylic Acids | 1 | 2010 | 75 | 0.020 |
Why?
|
Sphingomyelins | 1 | 2010 | 105 | 0.020 |
Why?
|
Motivation | 1 | 2020 | 2025 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 1992 | 569 | 0.020 |
Why?
|
Interprofessional Relations | 2 | 2007 | 997 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9384 | 0.020 |
Why?
|
Injections | 1 | 1992 | 841 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 11886 | 0.020 |
Why?
|
Cell Separation | 1 | 1994 | 1728 | 0.020 |
Why?
|
Infant | 4 | 2019 | 36556 | 0.020 |
Why?
|
Life Expectancy | 1 | 2016 | 1249 | 0.020 |
Why?
|
Prospective Studies | 4 | 2020 | 54962 | 0.020 |
Why?
|
Malnutrition | 1 | 2015 | 632 | 0.020 |
Why?
|
Shock, Septic | 1 | 2015 | 774 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10765 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 1994 | 1351 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1500 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 24333 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3492 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 411 | 0.020 |
Why?
|
Nucleotides | 1 | 2010 | 455 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2700 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6232 | 0.020 |
Why?
|
Healthy People Programs | 1 | 2007 | 54 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2009 | 463 | 0.020 |
Why?
|
Hemorrhage | 1 | 2018 | 3466 | 0.020 |
Why?
|
Phosphorus | 1 | 2007 | 336 | 0.020 |
Why?
|
Phenols | 1 | 2010 | 526 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2007 | 339 | 0.020 |
Why?
|
Internal-External Control | 1 | 1987 | 350 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 704 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15471 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3235 | 0.020 |
Why?
|
Flow Cytometry | 1 | 1996 | 5906 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6547 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26395 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2019 | 15889 | 0.010 |
Why?
|
Hypertension | 1 | 2004 | 8617 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20245 | 0.010 |
Why?
|
Survival Analysis | 2 | 2007 | 10115 | 0.010 |
Why?
|
Interinstitutional Relations | 1 | 2005 | 236 | 0.010 |
Why?
|
Adolescent | 5 | 2019 | 89244 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2815 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2019 | 26428 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9684 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2483 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5544 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1398 | 0.010 |
Why?
|
Models, Psychological | 1 | 1987 | 826 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8559 | 0.010 |
Why?
|
Cohort Studies | 3 | 2013 | 41808 | 0.010 |
Why?
|
Animals | 4 | 2015 | 169335 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9377 | 0.010 |
Why?
|
Child | 4 | 2019 | 80960 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2005 | 494 | 0.010 |
Why?
|
Triglycerides | 1 | 2010 | 2464 | 0.010 |
Why?
|
Educational Status | 2 | 2001 | 2515 | 0.010 |
Why?
|
Siblings | 1 | 2006 | 828 | 0.010 |
Why?
|
Models, Organizational | 1 | 2005 | 549 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5891 | 0.010 |
Why?
|
Skin | 1 | 2015 | 4506 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13318 | 0.010 |
Why?
|
Bone and Bones | 1 | 2011 | 2590 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2007 | 1803 | 0.010 |
Why?
|
Insulin | 1 | 1994 | 6610 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8094 | 0.010 |
Why?
|
Mutation | 1 | 2004 | 30266 | 0.010 |
Why?
|
Blood Glucose | 1 | 1994 | 6435 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13674 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23786 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 5047 | 0.010 |
Why?
|
Ethics, Medical | 1 | 2004 | 785 | 0.010 |
Why?
|
Goals | 1 | 2004 | 717 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 60131 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1992 | 3447 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 1996 | 22379 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12562 | 0.010 |
Why?
|
Stroke | 1 | 2018 | 9756 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14794 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18354 | 0.010 |
Why?
|
Angiography | 1 | 2001 | 1598 | 0.010 |
Why?
|
Polytetrafluoroethylene | 1 | 1996 | 245 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15879 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2945 | 0.010 |
Why?
|
Calcium | 1 | 2007 | 5792 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12095 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7478 | 0.010 |
Why?
|
Medicare | 1 | 2011 | 6888 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 13091 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 10633 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 13048 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3709 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15951 | 0.010 |
Why?
|
Research Design | 1 | 2005 | 6214 | 0.010 |
Why?
|
Mice | 1 | 1996 | 82072 | 0.000 |
Why?
|
Incidence | 1 | 2006 | 21547 | 0.000 |
Why?
|
Heart Failure | 1 | 2011 | 11879 | 0.000 |
Why?
|
Prognosis | 1 | 2006 | 30046 | 0.000 |
Why?
|